Defining outcome measures for psoriatic arthritis: A report from the GRAPPA-OMERACT working group

Alexis Ogdie; Maarten De Wit; Kristina Callis Duffin; Willemina Campbell; Jeffrey Chau; Laura C. Coates; Lihi Eder; Musaab Elmamoun; Oliver FitzGerald; Dafna D. Gladman; Niti Goel; Jana James; Umut Kalyoncu; John Latella; Chris Lindsay; Philip J. Mease; Denis O'Sullivan; Ingrid Steinkoenig; Vibeke Strand; William Tillett; Ana Maria Orbai

doi:10.3899/jrheum.170150

Defining outcome measures for psoriatic arthritis: A report from the GRAPPA-OMERACT working group

Alexis Ogdie, Maarten De Wit, Kristina Callis Duffin, Willemina Campbell, Jeffrey Chau, Laura C. Coates, Lihi Eder, Musaab Elmamoun, Oliver FitzGerald, Dafna D. Gladman, Niti Goel, Jana James, Umut Kalyoncu, John Latella, Chris Lindsay, Philip J. Mease, Denis O'Sullivan, Ingrid Steinkoenig, Vibeke Strand, William TillettAna Maria Orbai

School of Medicine

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group recently published the updated 2016 psoriatic arthritis (PsA) core domain set, a set of disease features that should be measured in all clinical trials. At the GRAPPA annual meeting in July 2016, the PsA working group presented the updated PsA core domain set endorsed by 90% of participants at OMERACT in May 2016 and drafted a roadmap for the development of the PsA core outcome measurement set. In this manuscript, we review the development process of the PsA core domain set and the ongoing and proposed work streams for development of a PsA core measurement set.

Original language	English (US)
Pages (from-to)	697-700
Number of pages	4
Journal	Journal of Rheumatology
Volume	44
Issue number	5
DOIs	https://doi.org/10.3899/jrheum.170150
State	Published - May 1 2017

Keywords

GRAPPA
Omeract
Outcome measures
Psoriasis
Psoriatic arthritis

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology

Access to Document

10.3899/jrheum.170150

Cite this

Ogdie, A., De Wit, M., Duffin, K. C., Campbell, W., Chau, J., Coates, L. C., Eder, L., Elmamoun, M., FitzGerald, O., Gladman, D. D., Goel, N., James, J., Kalyoncu, U., Latella, J., Lindsay, C., Mease, P. J., O'Sullivan, D., Steinkoenig, I., Strand, V., ... Orbai, A. M. (2017). Defining outcome measures for psoriatic arthritis: A report from the GRAPPA-OMERACT working group. Journal of Rheumatology, 44(5), 697-700. https://doi.org/10.3899/jrheum.170150

Ogdie, A, De Wit, M, Duffin, KC, Campbell, W, Chau, J, Coates, LC, Eder, L, Elmamoun, M, FitzGerald, O, Gladman, DD, Goel, N, James, J, Kalyoncu, U, Latella, J, Lindsay, C, Mease, PJ, O'Sullivan, D, Steinkoenig, I, Strand, V, Tillett, W & Orbai, AM 2017, 'Defining outcome measures for psoriatic arthritis: A report from the GRAPPA-OMERACT working group', Journal of Rheumatology, vol. 44, no. 5, pp. 697-700. https://doi.org/10.3899/jrheum.170150

@article{af4bddffbbd5474da1ff71f7721284a4,

title = "Defining outcome measures for psoriatic arthritis: A report from the GRAPPA-OMERACT working group",

abstract = "The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group recently published the updated 2016 psoriatic arthritis (PsA) core domain set, a set of disease features that should be measured in all clinical trials. At the GRAPPA annual meeting in July 2016, the PsA working group presented the updated PsA core domain set endorsed by 90% of participants at OMERACT in May 2016 and drafted a roadmap for the development of the PsA core outcome measurement set. In this manuscript, we review the development process of the PsA core domain set and the ongoing and proposed work streams for development of a PsA core measurement set.",

keywords = "GRAPPA, Omeract, Outcome measures, Psoriasis, Psoriatic arthritis",

author = "Alexis Ogdie and {De Wit}, Maarten and Duffin, {Kristina Callis} and Willemina Campbell and Jeffrey Chau and Coates, {Laura C.} and Lihi Eder and Musaab Elmamoun and Oliver FitzGerald and Gladman, {Dafna D.} and Niti Goel and Jana James and Umut Kalyoncu and John Latella and Chris Lindsay and Mease, {Philip J.} and Denis O'Sullivan and Ingrid Steinkoenig and Vibeke Strand and William Tillett and Orbai, {Ana Maria}",

year = "2017",

month = may,

day = "1",

doi = "10.3899/jrheum.170150",

language = "English (US)",

volume = "44",

pages = "697--700",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "5",

}

TY - JOUR

T1 - Defining outcome measures for psoriatic arthritis

T2 - A report from the GRAPPA-OMERACT working group

AU - Ogdie, Alexis

AU - De Wit, Maarten

AU - Duffin, Kristina Callis

AU - Campbell, Willemina

AU - Chau, Jeffrey

AU - Coates, Laura C.

AU - Eder, Lihi

AU - Elmamoun, Musaab

AU - FitzGerald, Oliver

AU - Gladman, Dafna D.

AU - Goel, Niti

AU - James, Jana

AU - Kalyoncu, Umut

AU - Latella, John

AU - Lindsay, Chris

AU - Mease, Philip J.

AU - O'Sullivan, Denis

AU - Steinkoenig, Ingrid

AU - Strand, Vibeke

AU - Tillett, William

AU - Orbai, Ana Maria

PY - 2017/5/1

Y1 - 2017/5/1

N2 - The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group recently published the updated 2016 psoriatic arthritis (PsA) core domain set, a set of disease features that should be measured in all clinical trials. At the GRAPPA annual meeting in July 2016, the PsA working group presented the updated PsA core domain set endorsed by 90% of participants at OMERACT in May 2016 and drafted a roadmap for the development of the PsA core outcome measurement set. In this manuscript, we review the development process of the PsA core domain set and the ongoing and proposed work streams for development of a PsA core measurement set.

AB - The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group recently published the updated 2016 psoriatic arthritis (PsA) core domain set, a set of disease features that should be measured in all clinical trials. At the GRAPPA annual meeting in July 2016, the PsA working group presented the updated PsA core domain set endorsed by 90% of participants at OMERACT in May 2016 and drafted a roadmap for the development of the PsA core outcome measurement set. In this manuscript, we review the development process of the PsA core domain set and the ongoing and proposed work streams for development of a PsA core measurement set.

KW - GRAPPA

KW - Omeract

KW - Outcome measures

KW - Psoriasis

KW - Psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=85018291384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018291384&partnerID=8YFLogxK

U2 - 10.3899/jrheum.170150

DO - 10.3899/jrheum.170150

M3 - Article

C2 - 28461531

AN - SCOPUS:85018291384

SN - 0315-162X

VL - 44

SP - 697

EP - 700

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 5

ER -

Defining outcome measures for psoriatic arthritis: A report from the GRAPPA-OMERACT working group

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this